Cargando…
Pyruvate dehydrogenase E1α represents a reliable prognostic predictor for patients with non-small cell lung cancer resected via curative operation
BACKGROUND: Lung cancer is associated with a high morbidity and mortality rate worldwide; however, no reliable and independent prognostic predictor for non-small cell lung cancer (NSCLC) after curative surgery is available. Glucose metabolism is correlated with cancer cell proliferation. Pyruvate de...
Autores principales: | Ito, Ryuichi, Yashiro, Masakazu, Tsukioka, Takuma, Izumi, Nobuhiro, Komatsu, Hiroaki, Inoue, Hidetoshi, Yamamoto, Yurie, Nishiyama, Noritoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575853/ https://www.ncbi.nlm.nih.gov/pubmed/34795919 http://dx.doi.org/10.21037/jtd-21-1463 |
Ejemplares similares
-
Usefulness of pyruvate dehydrogenase-E1α expression to determine SUVmax cut-off value of [(18)F]FDG-PET for predicting lymph node metastasis in lung cancer
por: Ito, Ryuichi, et al.
Publicado: (2023) -
GLUT1 and PKM2 may be useful prognostic predictors in patients with non‑small cell lung cancer following curative R0 resection
por: Ito, Ryuichi, et al.
Publicado: (2023) -
Completion lower lobectomy after basal segmentectomy for pulmonary sclerosing pneumocytoma with lymph node metastasis
por: Komatsu, Hiroaki, et al.
Publicado: (2021) -
Lung cancer surgery after COVID-19 infection in a patient with severe interstitial pneumonia and restrictive ventilatory impairment
por: Komatsu, Hiroaki, et al.
Publicado: (2022) -
Restrictive Ventilatory Impairment as a Poor Prognostic Factor in Patients Who Undergo Surgical Resection for Metachronous Second Primary Lung Cancer
por: Komatsu, Hiroaki, et al.
Publicado: (2023)